The FDA Generally Recognized As Safe (GRAS) process remains the mainstay by which ingredient manufacturers bring new innovative ingredients to the US market. While the process can be a detailed, transparent and effective means for regulatory substantiation, it has received its share of criticism and can be difficult to understand for ingredient developers outside of the US. Gain insights to:
- The perspective of a large ingredient supplier on how the GRAS process can be effectively leveraged
- How this perspective can provide transparency for regulators,
- A look at how this impacts CPG customers and consumers.
Understand GRAS as more than just regulatory slang.